Yuki Tachibana

1.6k total citations
31 papers, 654 citations indexed

About

Yuki Tachibana is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Yuki Tachibana has authored 31 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Yuki Tachibana's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Neurobiology and Insect Physiology Research (4 papers). Yuki Tachibana is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Neurobiology and Insect Physiology Research (4 papers). Yuki Tachibana collaborates with scholars based in Japan, Canada and Spain. Yuki Tachibana's co-authors include Shin‐Ichiro Nishimura, Kenji Monde, Sakae Tsuda, Garth L. Fletcher, Naoki Fujitani, Tetsuro Murahashi, T Tsuda, Fumio Nakajima, Shinnosuke Horiuchi and Kōji Yamamoto and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Yuki Tachibana

29 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Tachibana Japan 13 215 184 164 99 80 31 654
David N. Langelaan Canada 15 290 1.3× 57 0.3× 56 0.3× 144 1.5× 16 0.2× 32 611
Debjani Roy India 19 415 1.9× 106 0.6× 25 0.2× 45 0.5× 37 0.5× 53 986
Takao Furuki Japan 18 355 1.7× 51 0.3× 112 0.7× 26 0.3× 22 0.3× 33 1.0k
Satoshi Watabe Japan 18 425 2.0× 70 0.4× 70 0.4× 28 0.3× 127 1.6× 44 902
Vettai S. Ananthanarayanan Canada 16 414 1.9× 70 0.4× 110 0.7× 211 2.1× 9 0.1× 36 677
Zachary P. Gates United States 16 949 4.4× 416 2.3× 83 0.5× 42 0.4× 17 0.2× 24 1.2k
Brad L. Pentelute United States 21 1.3k 5.9× 661 3.6× 111 0.7× 41 0.4× 38 0.5× 26 1.4k
Luke M. Oltrogge United States 20 827 3.8× 58 0.3× 275 1.7× 116 1.2× 35 0.4× 26 1.3k
Xiaomeng Li China 20 814 3.8× 151 0.8× 45 0.3× 19 0.2× 12 0.1× 55 1.4k
Jennie G. Briard Canada 11 238 1.1× 102 0.6× 106 0.6× 14 0.1× 11 0.1× 13 549

Countries citing papers authored by Yuki Tachibana

Since Specialization
Citations

This map shows the geographic impact of Yuki Tachibana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Tachibana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Tachibana more than expected).

Fields of papers citing papers by Yuki Tachibana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Tachibana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Tachibana. The network helps show where Yuki Tachibana may publish in the future.

Co-authorship network of co-authors of Yuki Tachibana

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Tachibana. A scholar is included among the top collaborators of Yuki Tachibana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Tachibana. Yuki Tachibana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taoda, Yoshiyuki, Akihiro Hori, Satoru Tanaka, et al.. (2025). Design, synthesis and biological evaluation of novel quinazolinedione derivatives as non-covalent SARS-CoV-2 3CL protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 129. 130400–130400.
2.
Nobori, Haruaki, Keiko Baba, Takayuki Kuroda, et al.. (2024). Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2. Antiviral Research. 224. 105852–105852. 4 indexed citations
3.
Ito, Yuji, et al.. (2024). Evaluation of surface damage for in-service deteriorated agricultural concrete headworks using 3D point clouds by laser scanning method. Paddy and Water Environment. 22(2). 257–269. 2 indexed citations
4.
Kuroda, Takayuki, Haruaki Nobori, Keita Fukao, et al.. (2023). Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2in vitroandin vivo. Journal of Antimicrobial Chemotherapy. 78(4). 946–952. 26 indexed citations
5.
Kawashima, Sho, Yuki Matsui, Takumi Adachi, et al.. (2023). Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally. Biochemical and Biophysical Research Communications. 645. 132–136. 24 indexed citations
6.
Tachibana, Yuki, et al.. (2023). Report of Weil's disease with a fatal course triggered by Jarisch-Herxheimer reaction. Journal of Infection and Chemotherapy. 29(8). 800–802. 2 indexed citations
7.
Nobori, Haruaki, Keita Fukao, Takayuki Kuroda, et al.. (2022). Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model. Journal of Antimicrobial Chemotherapy. 77(11). 2984–2991. 20 indexed citations
8.
Tachibana, Yuki, et al.. (2021). A Novel Signal Power based Multi-targets Detection for FMCW Radar. 1–6. 2 indexed citations
9.
Tachibana, Yuki, et al.. (2020). HTR6 and SSTR3 ciliary targeting relies on both IC3 loops and C-terminal tails. Life Science Alliance. 4(3). e202000746–e202000746. 23 indexed citations
10.
Tachibana, Yuki, et al.. (2018). Extended Open‐Chain Polyenides as Versatile Delocalized Anion Ligands for Metal Chain Clusters. Chemistry - A European Journal. 25(5). 1212–1216. 11 indexed citations
11.
Akazawa, Takashi, Viskam Wijewardana, Norimitsu Inoue, et al.. (2017). Development of effective tumor immunotherapy using a novel dendritic cell–targeting Toll-like receptor ligand. PLoS ONE. 12(11). e0188738–e0188738. 8 indexed citations
12.
Kitao, Akihito, Ryuji Ieki, Yuki Tachibana, et al.. (2016). Severe fever with thrombocytopenia syndrome presenting as hemophagocytic syndrome: two case reports. SpringerPlus. 5(1). 361–361. 10 indexed citations
13.
Horiuchi, Shinnosuke, Yuki Tachibana, Kōji Yamamoto, et al.. (2015). Multinuclear metal-binding ability of a carotene. Nature Communications. 6(1). 6742–6742. 54 indexed citations
14.
Murahashi, Tetsuro, et al.. (2012). Selective Construction of Pd2Pt and PdPt2 Triangles in a Sandwich Framework: Carbocyclic Ligands as Scaffolds for a Mixed‐Metal System. Chemistry - A European Journal. 18(29). 8886–8890. 22 indexed citations
15.
Tachibana, Yuki. (2009). Bilingual Education for Immigrant Children in Hesse, Germany. 2009(38). 47–66. 1 indexed citations
16.
Matsumoto, Shuichiro, Hirofumi Kamachi, Yoshinori Furukawa, et al.. (2005). Effects of synthetic antifreeze glycoprotein analogue on islet cell survival and function during cryopreservation. Cryobiology. 52(1). 90–98. 61 indexed citations
17.
Nishimura, Shin‐Ichiro, et al.. (2004). Direct Observation of Sugar–Protein, Sugar–Sugar, and Sugar–Water Complexes by Cold‐Spray Ionization Time‐of‐Flight Mass Spectrometry. Angewandte Chemie. 117(4). 577–581. 1 indexed citations
18.
Tachibana, Yuki, Garth L. Fletcher, Naoki Fujitani, et al.. (2004). Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity. Angewandte Chemie International Edition. 43(7). 856–862. 190 indexed citations
19.
Nishimura, Shin‐Ichiro, et al.. (2004). Direct Observation of Sugar–Protein, Sugar–Sugar, and Sugar–Water Complexes by Cold‐Spray Ionization Time‐of‐Flight Mass Spectrometry. Angewandte Chemie International Edition. 44(4). 571–575. 18 indexed citations
20.
Tachibana, Yuki, Garth L. Fletcher, Naoki Fujitani, et al.. (2004). Antifreeze Glycoproteins: Elucidation of the Structural Motifs That Are Essential for Antifreeze Activity. Angewandte Chemie. 116(7). 874–880. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026